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Introduction/Purpose: Critical power (CP) is a fundamental parameter defining high-26	
intensity exercise tolerance, however its physiological determinants are incompletely 27	
understood. The present study determined the impact of hyperoxia on CP, the time constant 28	
of phase II pulmonary oxygen uptake kinetics (𝜏!O2), and muscle oxygenation (assessed by 29	
near-infrared spectroscopy) in 9 healthy men performing upright cycle ergometry. Methods: 30	
CP was determined in normoxia and hyperoxia (fraction of inspired O2 = 0.5) via 4 severe-31	
intensity constant load exercise tests to exhaustion on a cycle ergometer, repeated once in 32	
each condition. During each test, 𝜏!O2 and the time constant of muscle deoxyhaemoglobin 33	
kinetics (τ[HHb]), alongside absolute concentrations of muscle oxyhaemoglobin ([HbO2]), 34	
were determined. Results: CP was greater (hyperoxia: 216 ± 30 vs. normoxia: 197 ± 29W; P 35	
< 0.001) whereas W’ was reduced (hyperoxia: 15.4 ± 5.2 kJ, normoxia: 17.5 ± 4.3 W; P = 36	
0.037) in hyperoxia compared to normoxia. 𝜏!O2 (hyperoxia: 35 ± 12 vs normoxia: 33 ± 10 s; 37	
P = 0.33) and τ[HHb] (hyperoxia: 11 ± 5 vs. normoxia: 14 ± 5 s; P = 0.65) were unchanged 38	
between conditions, whereas [HbO2] during exercise was greater in hyperoxia compared to 39	
normoxia (hyperoxia: 73 ± 20 vs. normoxia: 66 ± 15 µM; P = 0.001). Conclusion: This study 40	
provides novel insights into the physiological determinants of CP and by extension, exercise 41	
tolerance. Microvascular oxygenation and CP were improved during exercise in hyperoxia 42	
compared with normoxia. Importantly, the improved microvascular oxygenation afforded by 43	
hyperoxia did not alter 𝜏!O2,	suggesting that microvascular O2 availability is an independent 44	
determinant of the upper limit for steady-state exercise, i.e. CP. 45	
Keywords: critical power, exercise tolerance, oxidative metabolism, oxygen uptake kinetics, 46	
power-duration relationship, hyperoxia. 47	
	48	
INTRODUCTION 49	
The relationship between power output and the tolerable duration of high-intensity exercise 50	
takes the form of a rectangular hyperbola and is defined by two parameters: critical power 51	
(CP), representing the asymptote of the curve, and W’, the rectangular constant of the 52	
hyperbola representing the finite work capacity available above CP (1). CP represents the 53	
boundary delineating the heavy and severe exercise intensity domains (1,2). During heavy-54	
intensity exercise, a delayed steady-state can be attained for pulmonary oxygen uptake (𝑉O2) 55	
and the intramuscular metabolic responses to exercise (1–3). In contrast, the challenge to 56	
system homeostasis during severe-intensity exercise is such that a steady-state cannot be 57	
attained for 𝑉O2, with the slow component driving 𝑉O2 towards its maximally attainable 58	
value (𝑉O2 max) with the limit of tolerance being reached shortly thereafter. The pulmonary 59	
𝑉O2 response is reflective of the intramuscular metabolic responses during exercise above 60	
CP, with muscle lactate ([L-]) and inorganic phosphate ([Pi]) reaching maximal values and 61	
intramuscular phosphocreatine ([PCr]) and pH reaching a nadir immediately prior to the limit 62	
of tolerance (1,2).  CP and W’ therefore conflate to determine the tolerable duration of severe 63	
intensity exercise, which is predictably limited as a function of the power output above CP 64	
and the size of the W’. 65	
At the onset of exercise, pulmonary 𝑉O2 kinetics are well-characterised by an exponential 66	
function, following a brief delay termed phase I (4). This “fundamental” increase in 𝑉O2 can 67	
be characterised by a time constant (𝜏!O2) that, in healthy humans, has previously been shown 68	
to reflect the kinetics of muscle 𝑉O2 (𝑉O2m) (5). We have recently provided evidence to 69	
suggest that 𝜏!O2 is an independent determinant of CP (6–9). Specifically, when 𝜏!O2 was 70	
acutely reduced, CP increased (7,9), whereas when 𝜏! O2 was acutely increased, CP 71	
correspondingly decreased (6,8). A potential explanation for this seemingly causal 72	
relationship between 𝜏!O2 and CP is that CP represents the highest work rate for which 73	
accumulation of the O2 deficit can be stabilised (10). Hence, as 𝜏! O2 determines the 74	
magnitude of the O2 deficit, a smaller 𝜏!O2 would enable the same O2 deficit accumulation to 75	
be stabilised for a higher work rate, thus increasing CP.  76	
The inspiration of a hyperoxic gas mixture increases the driving pressure for peripheral 77	
diffusion of O2 from capillary to mitochondria (11). As such, improved high-intensity 78	
exercise performance (12,13) has been reported during hyperoxia. However, hyperoxia does 79	
not appear to speed the pulmonary 𝑉O2 kinetics during upright cycling (13–15), which is 80	
seemingly inconsistent with the putative linkage between 𝜏!O2 and CP previously described 81	
(6–9). Nevertheless, Vanhatalo et al. (16) previously demonstrated that CP was increased 82	
when determined in hyperoxia compared to normoxia, suggesting a central role for O2 83	
availability per se in determining CP. However, Vanhatalo et al. (16) did not determine 𝑉O2 84	
kinetics, and the prone position employed in this study would have impaired perfusion 85	
pressure (17), raising the possibility that the increased CP these authors observed in 86	
hyperoxia may have been due to faster 𝑉O2 kinetics in this condition, rather than improved 87	
O2 availability per se. Furthermore, in a recent study we demonstrated that hyperoxia speeded 88	
pulmonary 𝑉O2 kinetics and increased CP during supine exercise, but that the change in 𝜏!O2 89	
did not correlate linearly with the change in CP (9). Taken together, the relative, independent 90	
contributions of 𝜏!O2 and O2 availability in determining CP remain uncertain.  91	
A convenient means by which to investigate the dependency of CP on O2 availability, 92	
independent of the effects of 𝜏!O2, is via the use of hyperoxia in young healthy individuals 93	
performing upright cycle exercise, where a speeding of 𝑉O2 kinetics would not be expected 94	
(13, 15). Hence, if O2 availability is an independent determinant of CP, then hyperoxia would 95	
be expected to increase CP without a concomitant reduction in 𝜏!O2.  Conversely, if the role 96	
of O2 availability in determining CP is merely via its contribution to 𝜏!O2 then no change in 97	
CP between conditions of hyperoxia and normoxia would be expected.  98	
The aim of this study was therefore to assess the effect of hyperoxia on pulmonary 𝑉O2 99	
kinetics and CP during upright cycle exercise. Our hypotheses were threefold: 1) CP would 100	
be greater in hyperoxia compared to normoxia; 2) 𝜏!O2 would not differ between hyperoxia 101	
and normoxia; and 3) microvascular oxygenation (as assessed by near-infrared spectroscopy; 102	
NIRS) would be improved in hyperoxia compared to normoxia.  103	
METHODS 104	
Nine healthy male subjects (mean ± SD, age = 23 ± 3 years; height = 179 ± 8 cm; mass = 77 105	
± 8 kg) who were recreationally active provided written informed consent for participation. 106	
The experiment was approved by the Institutional Research Ethics Committee. Participants 107	
were asked to avoid alcohol and strenuous exercise 24 h prior to each visit, not to consume 108	
caffeine 3 h prior to each visit, and to arrive 3 h postprandial. Tests were separated by at least 109	
24 h, with each test performed at the same time of day (± 2 h). 110	
Procedures. All tests took place in a temperature-controlled laboratory that was maintained 111	
between 18-21 oC. The experiment involved nine visits over a 3-5 week period, including one 112	
preliminary trial and eight experimental trials. All tests were performed on the same 113	
electronically-braked cycle ergometer (Lode Excalibur Sport, Groningen, The Netherlands). 114	
The ergometer seat and handlebar configuration were recorded at the first visit and replicated 115	
during each subsequent visit. Throughout all exercise tests, participants were instructed to 116	
cycle at a self-selected cadence between 70-90 rev/min (which was recorded and replicated in 117	
subsequent visits), with task failure being defined as the point at which the cadence dropped 118	
below 50 rev/min. Time to task failure was recorded to the nearest second in all tests.  119	
Preliminary trial. Height and body mass were recorded, after which participants undertook an 120	
incremental ramp test to task failure to determine 𝑉O2 max and the gas exchange threshold 121	
(GET), such that the power outputs for subsequent visits could be calculated. The ramp test 122	
consisted of 3 min baseline pedalling at 30 W, followed by a ramped increase in power of 30 123	
W.min-1 until task failure occurred. Ventilatory and gas exchange variables were measured 124	
continuously breath-by-breath throughout each test. 𝑉O2 max was defined as the highest 30 s 125	
value. The GET was estimated via visual determination of the time point at which the 126	
following occurred: 1) excessive CO2 output (𝑉CO2) relative to 𝑉O2, 2) increased minute 127	
ventilation (𝑉E) relative to 𝑉O2 (𝑉E/𝑉O2) without an increase in 𝑉E/𝑉CO2, and 3) an 128	
increase in end tidal O2 tension without decreasing end tidal CO2 tension. The mean response 129	
time (MRT) was determined as the time between the beginning of the ramp test and 130	
intersection between baseline 𝑉O2 (average 𝑉O2 measured during last 30 s of baseline; 𝑉O2b) 131	
and backwards extrapolation of the 𝑉O2-time relationship (18). This technique was also used 132	
to calculate power outputs for subsequent visits.  133	
Experimental trials. The subsequent eight visits required exhaustive exercise at one of four 134	
fixed severe-intensity power outputs, each repeated twice: once in normoxia (breathing 135	
atmospheric air) and once in hyperoxia (FiO2 0.5, in balance N2, British Oxygen Company). 136	
These power outputs were selected to span a range of 50%Δ (i.e. 50% of the difference 137	
between the GET and 𝑉O2 max) – 110% 𝑉O2 max, such that the range of exercise tolerance 138	
times was 2-15 minutes for each subject (19). When a particular test deviated from this range, 139	
the power output was modified and the test was repeated on a separate day. These power 140	
outputs are subsequently referred to as WR1, WR 2, WR 3, and WR 4, with WR 1 being the 141	
lowest and WR 4 being the highest power outputs, respectively. The power outputs were 142	
presented in random order, and participants alternated between hyperoxic and normoxic 143	
conditions. In both conditions, tests began with 3 minutes of baseline pedalling at 20 W, 144	
followed by a step increase in power output to 70% GET for 6 minutes for the 145	
characterisation of the 𝑉O2 kinetics during moderate exercise. Following these 6 minutes of 146	
moderate cycling, the power output was decreased to 20 W for 6 minutes, after which a step 147	
increase in power was applied to the desired severe-intensity power output, and participants 148	
exercised until task failure occurred.  149	
Pulmonary gas exchange and ventilation were measured breath-by-breath throughout all tests 150	
using a metabolic cart (Blue Cherry, Geratherm Respiratory, GmbH, Germany), with 151	
participants wearing a silicone face mask (Hans Rudolph, Kansas, United States) attached to 152	
a differential pressure flow sensor (Geratherm Respiratory, GmbH, Germany, resistance 153	
<0.12 kPa, dead space < 32 mL)  The metabolic cart was connected to the participant via a 154	
capillary line connected to the flow sensor. Expired gases were measured using an 155	
electrochemical cell O2 analyser (rise time: t10-90 < 90 ms) and a principle infrared 156	
spectroscopy CO2 analyser (rise time: t10-90 < 90 ms), which were calibrated before and 157	
after each test using gases of known concentration. The gas sampling rate was 125 MHz. 158	
Flow sensors were calibrated using a 3-liter syringe (Hans Rudolph, Kansas City, MO). The 159	
software of the metabolic unit was specifically adapted to measure FiO2 during both 160	
inspiration and expiration (instead of assuming constant FiO2), whereas the delay time 161	
between airflow and gas concentration signals was first determined during calibration and the 162	
synchronization between these signals was continuously optimized during every inspiration 163	
throughout each test. The flow sensor was attached to a two-way non-rebreathing valve (Hans 164	
Rudolph T-Shape Two-Way Non-Rebreathing Valve Series 2600; Hans Rudolph, Kansas, 165	
United States) via rubber tubing. The inlet port of this valve was connected to a 200 L 166	
Douglas bag. In the hyperoxic condition, the Douglas bag was continuously filled with the 167	
hyperoxic gas mixture, and in the normoxic condition the Douglas bag was bypassed so that 168	
participants breathed room air; participants were not informed of the condition they were 169	
exercising in. In both conditions participants rested quietly on the ergometer for 10 minutes 170	
prior to the commencement of exercise, breathing either the hyperoxic inspirate or normoxic 171	
room air, to allow equilibration of body O2. 20 µL of blood was drawn from the thumb of the 172	
right hand at rest, during the final minute of baseline pedalling before the onset of severe 173	
exercise, and immediately following task failure into sodium heparinized plastic capillary 174	
tubes (EKF Diagnostics, Cardiff, Wales, UK) before being placed into an Eppendorf 175	
containing a glucose/ L- haemolysing solution and being vigorously shaken until the sample 176	
had mixed adequately.. Whole blood L- was determined using a Biosen lactate analyser 177	
(Biosen C-Line, EKF, Germany). 178	
Absolute concentrations of muscle and microvascular deoxyhaemoglobin + deoxymyoglobin 179	
([HHb + Mb]), oxyhaemoglobin +oxymyoglobin ([HbO2 + MbO2]), and total haemoglobin + 180	
total myoglobin ([THb + Mb]) were determined using a frequency-domain multidistance 181	
NIRS system (OxiplexTS, ISS, Chapaign, IL, USA). This technique has been described in 182	
detail previously (7,20). The device measures and incorporates dynamic reduced scattering 183	
coefficients to provide absolute concentrations of [HHb + Mb] and [HbO2 + MbO2]. The 184	
NIRS probe was calibrated prior to each test according to the manufacturer’s instructions. 185	
Two flexible NIRS probes were placed on the participant; one longitudinally along the belly 186	
of the right vastus lateralis (VL), the other longitudinally along the belly of the rectus femoris 187	
(RF) muscle. The probes were held firmly in place via Velcro strapping, and the area 188	
underneath the probe was cleaned, shaved and marked with pen such that probe position 189	
could be accurately replicated for each trial. To account for the influence of adipose tissue 190	
thickness (ATT) on the NIRS signal, we utilised the correction factor of Bowen et al. (21), 191	
albeit with separate correction factors for the RF and VL. 192	
Data analysis. Raw breath-by-breath 𝑉O2 were edited to remove data points lying more than 193	
4 standard deviations (SD) outside the local 5-breath mean (22). Edited 𝑉O2 were then 194	
subsequently linearly interpolated to provide second-by-second values. During moderate 195	
intensity exercise, second-by-second 𝑉O2 and [HHb + Mb] data for the four identical 196	
transitions were averaged together to produce a single dataset for each condition. The severe-197	
intensity exercise bouts were not repeated and therefore were modelled separately. The 𝑉O2 198	
and [HHb + Mb] responses to transitions were modelled utilising the following mono-199	
exponential function: 200	
(1) Y(t) = Y(b) + AY * (1 – e – (t – TD/ τ)) 201	
 202	
Where Y(t) is the value of the independent variable at time t, Y(b) is the baseline value 203	
measured over the final 30 seconds of baseline, AY is the amplitude of increase in Y above 204	
baseline, TD is the time delay relative to the onset of exercise and τ is the time constant of the 205	
response.  206	
𝑉O2 data preceding the time point at which a drop in respiratory exchange ratio and end-tidal 207	
O2 pressure was observed were excluded from the modelling process. 𝑉O2 responses to 208	
moderate exercise were fit to the end of exercise whereas for severe-intensity exercise, the 209	
onset of the slow component was determined by iteratively lengthening the fitting window in 210	
1 second intervals from 60 seconds to end-exercise. The onset of the slow component was 211	
taken as the point at which there was a departure from a plateau in the plot of 𝜏!O2 and χ
2                                                                                              212	
versus time, as described previously (7,17) with TD, τ and Ay determined from this fitting 213	
window. The magnitude of the 𝑉O2 slow component was calculated as the difference between 214	
end exercise 𝑉O2 (i.e. mean 𝑉O2 over final 30 s of exercise) and Ay + Y(b).		215	
The onset of the fundamental rise in [HHb + Mb] was taken as the time point at which the 216	
[HHb + Mb] signal increased above 1 SD of the pretransition baseline value. On occasions 217	
where [HHb + Mb] decreased after the exercise onset, the onset of the fundamental increase 218	
in [HHb + Mb] was taken as the first point following the nadir showing a sustained increase 219	
in [HHb + Mb]. This time-point defined TD for [HHb + Mb] kinetics, with data preceding 220	
this being excluded from the modelling process, during which TD was allowed to vary. For 221	
moderate exercise, [HHb + Mb] responses were fit with equation 1 using the iterative 222	
procedures described for the determination of the 𝑉O2 kinetics but with the fitting window 223	
commencing at 20 s. This modelling strategy thus allows for the determination of the 224	
optimum “phase II” fitting window even in the presence of a [HHb + Mb] overshoot. By 225	
plotting the resultant τ[HHb+Mb] values against time and identifying the point at which a 226	
sustained decrease (overshoot) or increase in τ[HHb+Mb] was observed alongside a sharp 227	
increase in the χ2 value. For severe-intensity exercise, the model window was constrained to 228	
the TD before the onset of the 𝑉O2 slow component. The amplitude of the [HHb + Mb] 229	
during severe exercise was calculated by subtracting Y(b) + AY from the mean value of Y 230	
during the final 30 s of exercise. The spatial heterogeneity of TD[HHb+Mb] and τ[HHb+Mb] was 231	
calculated for each participant using the intersite coefficient of variation (CV% = 100 * SD/ 232	
mean of the two sites). Confidence intervals for all τ parameters were obtained in Origin 6.0 233	
(OriginLab Corporation, MA, USA). For [HbO2 + MbO2] and [THb + Mb] during moderate 234	
exercise, 30 second averages were determined at baseline, and every 30 seconds thereafter 235	
until the end of the transition. For severe exercise, mean [HbO2 + MbO2] and [THb + Mb] 236	
was determined at baseline, at 30 and 120 seconds into the transition (15 second bins centred 237	
on each time point), and at end-exercise (final 30 seconds) to allow comparisons between 238	
conditions.  239	
CP and W’ were determined by inputting power output, time to task failure and work done 240	
into three models: the hyperbolic power-time (P-T) model (Eq. 2), the linear work-time (W-241	
T) model (Eq. 3), and the linear power versus the inverse-of-time (1/T) models: 242	
(2)     P = W’ / T + CP         243	
(3)     W = CP * T + W’       244	
(4)     P = W’ * (1/T) + CP     245	
The standard errors of the estimates (SEE) associated with CP and W’ were expressed as a 246	
coefficient of variation (CV) relative to the parameter estimate. Best individual fit parameter 247	
estimates were obtained for each participant by selecting the model that produced the lowest 248	
summed CV for both parameters across conditions.  249	
Statistical analyses. All kinetic parameters (i.e. 𝑉O2, [HHb + Mb]) and spatial heterogeneity 250	
of [HHb + Mb] during severe exercise, blood [L-], [HbO2 + MbO2] and [THb + Mb] were 251	
analysed using two-way -way repeated measures ANOVAs (condition * work rate, condition 252	
* muscle, condition * time, work rate * time, work rate * muscle, muscle * time), as 253	
appropriate. Where significant differences were found, planned repeated and simple contrasts 254	
were used to determine where the differences were located. 𝑉O2 and spatial heterogeneity of 255	
[HHb + Mb] for moderate exercise as well as differences in CP and W’ between conditions 256	
were compared using student’s paired t-tests. Pearson’s correlation coefficient was used to 257	
determine relationships between variables of interest. All data are presented as mean ± SD 258	
unless otherwise stated. For clarity, and to highlight values for parameters measured across 259	
all four severe-intensity work rates, the overall mean across work rates ± SD is presented in 260	
text, with work rate-specific mean ± SD presented in tables. Statistical significance was 261	
accepted at P < 0.05. 262	
RESULTS 263	
𝑉O2 max determined from the ramp test was 3.99 ± 0.70 L.min-1 (51 ± 5 mL.kg-1.min-1), and 264	
this was achieved at a peak work-rate of 322 ± 36 W. The GET was 1.93 ± 0.14 L.min-1 (108 265	
± 15 W), and thus the moderate exercise bouts at 70% GET were conducted at 76 ± 11 W. 266	
Blood [L-] did not differ between rest and baseline (normoxia rest: 1.40 ± 0.20, hyperoxia 267	
rest: 1.14 ± 0.21, normoxia baseline: 1.44 ± 0.18, hyperoxia baseline: 1.53 ± 0.50 mmol.L-1), 268	
however blood [L-] was increased at end-exercise (normoxia: 10.81 ± 1.85, hyperoxia: 11.07 269	
± 2.26 mmol.L-1; main effect of time, P < 0.001). There was no main effect of condition on 270	
blood L- (P = 0.91).    271	
Individual fit optimisation resulted in the hyperbolic P-T model being used for 7 participants, 272	
the W-T model for 1 participant, and the 1/T model for 1 participant. CP was greater in 273	
hyperoxia than in normoxia (hyperoxia: 216 ± 30, normoxia: 197 ± 29 W; P < 0.001; Figure 274	
1A), whereas W’ was reduced in hyperoxia compared to normoxia (hyperoxia: 15.4 ± 5.2 kJ, 275	
normoxia: 17.5 ± 4.3 W; P = 0.037; Figure 1B).   276	
The group mean 𝑉O2 responses to moderate exercise in each condition are displayed in 277	
Figure 2A, whereas 𝑉O2 responses to severe exercise at a representative work rate from a 278	
representative participant in each condition are displayed in Figure 2B. 𝜏!O2 did not differ 279	
between conditions during moderate (hyperoxia: 25 ± 6, normoxia: 24 ± 9 s; P = 0.49) or 280	
severe exercise (hyperoxia: 35 ± 12, normoxia: 33 ± 10 s; P = 0.33). There were also no 281	
differences between conditions for any of the other parameters of 𝑉O2 kinetics during 282	
moderate exercise (Figure 2A). For severe exercise, there was no difference in 𝑉O2 peak 283	
between constant work rate trials within each condition or between any of the constant work 284	
rate trials in normoxia and the 𝑉O2 peak obtained in the ramp incremental test (Table 1, both 285	
P > 0.05). 𝐴!!!and 𝑉O2 peak were greater in hyperoxia compared to normoxia (Table 1, 286	
Figure 2B; both P < 0.001), however there were no other differences in the parameters of the 287	
𝑉O2 kinetics during severe exercise (Table 1). 𝜏!O2 during moderate exercise was inversely 288	
correlated with CP in normoxia (R2 = 0.85; P < 0.001), and in hyperoxia (R2 = 0.56; P = 289	
0.021). End-tidal PO2 was increased in hyperoxia compared to normoxia at baseline 290	
(hyperoxia: 308 ± 7, normoxia: 106 ± 4 mmHg; P < 0.001) and end-exercise (hyperoxia: 315 291	
± 9, normoxia: 121 ± 4 mmHg; P < 0.001). 292	
[HbO2 + MbO2] was increased during both moderate (hyperoxia: 74 ± 21 µM, normoxia: 68 293	
± 18; main effect of condition, P < 0.001, Figure 4A) and severe (hyperoxia: 73 ± 20 µM, 294	
normoxia: 66 ± 15; main effect of condition, P = 0.039, Figure 4B) exercise. [THb + Mb] was 295	
unchanged during both moderate (hyperoxia: 99 ± 18 µM, normoxia: 99 ± 21; no main effect 296	
of condition, P = 0.97) and severe (hyperoxia: 106 ± 13 µM, normoxia: 104 ± 17; no main 297	
effect of condition, P = 0.88) exercise. Baseline and end-exercise [HHb + Mb] were reduced 298	
during moderate exercise (Figure 3A,  both P < 0.001), however there were no differences 299	
between conditions with regard to any of the other [HHb + Mb] kinetic parameters during 300	
either moderate (Figure 3A) or severe exercise (Figure 3B, Table 2). Furthermore, the spatial 301	
heterogeneity of τ[HHb + Mb] and TD[HHb + Mb] did not differ between conditions during moderate 302	
nor severe exercise (all P > 0.05).  CP did not correlate with [HbO2 + MbO2] in either the RF 303	
or VL in either condition or at any time point (R2 range, RF: 0.09 – 0.43, VL: 0.10 – 0.31, P 304	
> 0.05 for all comparisons), whereas the change in CP between conditions did not correlate 305	
with changes in [HbO2 + MbO2] between conditions in either the RF or VL at any time point 306	
(R2 range, RF: 0.01 – 0.15, VL: 0.06 – 0.37), P > 0.05 for all comparisons). 307	
 308	
DISCUSSION  309	
Recent work from our laboratory has provided strong evidence that pulmonary 𝑉O2 kinetics 310	
are an independent determinant of CP: we have demonstrated that a speeding of the 𝑉O2 311	
kinetics increases CP (7,9), and also that a slowing of the 𝑉O2 kinetics decreases CP (6,8). 312	
However, since two of these previous studies involved interventions that also enhance O2 313	
availability (i.e. priming exercise and hyperoxia), whether the speeding of 𝑉O2 kinetics we 314	
noted previously (7,9) was the sole cause of the increases in CP observed in these studies, or 315	
whether muscle O2 availability also independently determines CP, was unclear. The present 316	
study therefore sought to determine whether CP is primarily determined by 𝜏!O2, or whether 317	
microvascular O2 availability also independently determined CP. Given that in healthy, 318	
young individuals performing upright cycle exercise, muscle O2 availability does not appear 319	
to be the rate-limiting factor for the speed of the 𝑉O2 kinetics (15, 26), we employed 320	
hyperoxia as a means to test the independent effect of increased microvascular O2 availability 321	
on CP during upright cycling. Hyperoxia improved microvascular oxygenation during 322	
exercise (assessed via NIRS), increased the fundamental phase 𝑉O2 amplitude, and increased 323	
CP when compared to normoxia. 𝜏!O2 was significantly related to CP in both normoxia and 324	
hyperoxia, consistent with the notion that 𝜏! O2 is an independent determinant of CP. 325	
However, 𝜏!O2 was unchanged between conditions. These findings therefore suggest that in 326	
addition to 𝜏!O2, microvascular oxygenation is also an independent determinant of CP.  327	
In this present study we found that CP was ~19 W greater in hyperoxia when compared to 328	
normoxia. This finding is consistent with previous reports of improved aerobic exercise 329	
performance in hyperoxia (12,13). Furthermore, Vanhatalo et al. (16) previously 330	
demonstrated an increase in CP of ~10% in hyperoxia during small muscle mass exercise in 331	
the prone position, similar to the magnitude reported herein. CP has also been shown to be 332	
reduced in hypoxia (24), and thus it appears CP is highly dependent on FiO2 and thus the 333	
state of O2 availability. However, prior to the present study it was unknown whether the 334	
influence of FiO2 on CP was due to enhanced O2 availability per se, or mediated by the 335	
potential effects of FiO2 on pulmonary 𝑉O2 kinetics.  336	
The present findings therefore extend those of Vanhatalo et al. (16) by demonstrating that CP 337	
is improved by hyperoxia during large muscle mass, upright cycle exercise and provides 338	
further evidence to the growing body of literature demonstrating that CP is an important 339	
parameter of aerobic function (6,10,16,20,25). In the present study, end-tidal PO2 (and, 340	
therefore, alveolar PO2) was enhanced in hyperoxia at baseline and end-exercise when 341	
compared to normoxia. Resultant increases in microvascular oxygenation are demonstrated 342	
by a reduced baseline and steady-state [HHb + Mb] during moderate exercise in hyperoxia, 343	
and an increased [HbO2 + MbO2] in hyperoxia during exercise at all intensities, when 344	
compared to normoxia. These observations are consistent with studies demonstrating that 345	
hyperoxia increases arterial O2 concentration, capillary O2 pressure (PO2) (26,27), and 346	
intracellular PO2 (11), suggesting that the capillary driving pressure for O2 diffusion was 347	
increased in this condition. Additionally, we saw no between-condition differences in the CV 348	
for τ[HHb + Mb] and TD[HHb + Mb], suggesting that the spatial distribution of O2 delivery was 349	
unaffected by hyperoxia. This combination of enhanced microvascular oxygenation (as 350	
inferred from the reduced [HHb + Mb] and increased [HbO2 + MbO2]) with an unchanged 351	
spatial distribution of O2 would thus likely have improved the overall potential for peripheral 352	
O2 diffusion in hyperoxia. The finding of no between-condition differences with respect to 353	
𝜏!O2 during either moderate or severe upright cycle exercise is consonant with previous 354	
reports (13,14,28), and bolsters the notion that O2 availability is generally not the crucial rate-355	
limiting step for oxidative metabolism in physically active, young individuals undertaking 356	
upright exercise (29). Hence the present data suggests that the differences in CP observed 357	
between conditions are instead likely attributable to the increased microvascular oxygenation 358	
observed in the hyperoxic condition. Taken together, the results of the present experiment 359	
therefore suggest that O2 availability within the exercising musculature is, in addition to 𝜏!O2 360	
(6–9), an independent determinant of CP. Alternatively, the increased CP observed in the 361	
hyperoxic condition in the present study may instead have been attributable to the subsequent 362	
effects of increased microvascular oxygenation on the fundamental phase 𝑉O2 amplitude 363	
observed in this condition. The fundamental phase 𝑉O2 amplitude was enhanced in hyperoxia 364	
relative to normoxia, consistent with previous observations that the fundamental 𝑉O2 365	
amplitude is sensitive to manipulations in O2 delivery (13). However, interventions which 366	
alter the fundamental phase 𝑉O2 amplitude, do not consistently affect CP (7). Therefore it 367	
appears problematic to ascribe the presently observed effects of hyperoxia on CP to operate 368	
via their impact on the fundamental 𝑉O2 amplitude. Hence, we suggest that the improvement 369	
in CP in hyperoxia noted herein was primarily due to the increased microvascular 370	
oxygenation observed in this condition, rather than the secondary effects of improved 371	
microvascular oxygenation on  𝑉O2 kinetics. 372	
Our previously demonstrated dependence of CP on the speed of the 𝑉O2 kinetics (6–8) may 373	
be, at least in part, explained by the [ADP] - 𝑉O2 relationship. During exercise, increases in 374	
[ADP] stimulate 𝑉O2 via a relationship that has been shown to be sigmoidal in vivo (30).  At 375	
high metabolic rates therefore the “plateau” region of the curve is approached, and thus the 376	
𝑉O2 response to a given increment in [ADP] becomes progressively smaller with increasing 377	
metabolic rate. Thus, a potential explanation for our previously noted dependence of CP on 378	
𝜏!O2 may be that CP represents the work-rate at which a critical [ADP] is attained beyond 379	
which the 𝑉O2 response to further elevations in [ADP] is ultimately insufficient to meet the 380	
demands for ATP turnover, causing a cascade of metabolic events that prohibit the attainment 381	
of steady state (10).  𝜏!O2 therefore determines CP since a smaller 𝜏!O2 (i.e. faster 𝑉O2 382	
kinetics) will lessen the rise in intracellular [ADP] during a given exercise transition (31), 383	
thus increasing the work-rate at which a “critical [ADP]” is attained. Despite this hypothesis, 384	
the precise mechanisms underpinning the determining effect of 𝜏!O2 on CP remains to be 385	
elucidated.  Indeed in the present study, 𝜏!O2 was unchanged between conditions despite an 386	
increase in CP with hyperoxia.  Nevertheless, this remains consistent with the suggestion of 387	
an underlying critical [ADP] because [ADP] is highly dependent upon intracellular PO2 (32–388	
35), such that a greater intracellular PO2 increases  the 𝑉O2 achieved for a given change in 389	
intracellular [ADP] (12). In the present study we therefore suggest that the increased CP in 390	
hyperoxia was due to a reduced perturbation to [ADP] during the rest-to-exercise transition of 391	
the criterion bouts, consequent to an elevated microvascular and intracellular PO2 (indirectly 392	
inferred from the elevated [HbO2 + MbO2]). This would be predicted to increase CP by virtue 393	
of an increase in the work-rate at which either a critical [ADP] is attained during the rest-to-394	
exercise transition. Hence the present data suggest that O2 availability, in addition to 𝜏!O2 (6–395	
9), is an independent determinant of CP.  Furthermore, the role of O2 availability per se in 396	
determining CP is also implied by the data of Mitchell et al. (25), which demonstrated that 397	
CP was strongly positively correlated with the number of capillary contacts per type I muscle 398	
fibre. A high number of capillary contacts per type I muscle fibre would enhance the potential 399	
for peripheral O2 diffusion, and thus also raise the intracellular PO2, in muscle fibres 400	
recruited at the onset of exercise.  401	
Despite the finding that hyperoxia increased microvascular oxygenation (inferred via NIRS) 402	
and enhanced critical power, we found no relationship between the changes in CP and [HbO2 403	
+ MbO2] (i.e. ΔCP vs. Δ[HbO2 + MbO2]) between conditions. This finding may suggest that 404	
other factor(s) may have been responsible for the increased CP in hyperoxia, rather than an 405	
increase in microvascular, and thus intracellular, PO2. An alternative explanation is that our 406	
NIRS measurements did not have sufficient spatial resolution to quantitatively capture the 407	
increase in microvascular O2 availability across the entire exercising muscle mass. Skeletal 408	
muscle is a structurally and functionally heterogeneous tissue, and muscle deoxygenation and 409	
activation have been shown to be regionally heterogeneous during exercise (29). Thus, whilst 410	
we have improved our spatial resolution by measuring two muscle sites, NIRS interrogates a 411	
relatively superficial portion of muscle and a small fraction of the exercising muscle mass. 412	
Consequently, ΔCP and Δ[HbO2 + MbO2] do not scale with each other because the NIRS 413	
parameters are a poor reflection of the precise value of oxygen availability to the recruited 414	
muscle cells. Notwithstanding this, the notion that whole-body and microvascular 415	
oxygenation was enhanced in hyperoxia in the present study is supported by the increased 416	
end-tidal PO2, increased fundamental phase 𝑉O2 amplitude, [HbO2 + MbO2] and reduced 417	
[HHb + Mb] in hyperoxia compared to normoxia.  418	
We observed a ~2 kJ reduction in W’ in hyperoxia, consistent with previous reports (16). A 419	
possible explanation for this finding is that hyperoxia increased CP to a greater extent than 420	
the 𝑉O2 max. This would necessitate a decrease in W’, because the applicable range of work-421	
rates in the severe domain would be reduced (16). However, the increase in 𝑉O2 peak in 422	
hyperoxia in the present study (~ 0.25 L.min-1) was similar to the increase in 𝑉O2 that would 423	
correspond with the average increase in CP of 19 W (assuming a gain of 10 – 13 ml.min-1.W-424	
1, 38) also observed in this condition. An alternative explanation, therefore, is that the amount 425	
of metabolic energy available from anaerobic metabolism is dependent upon the degree of O2 426	
availability (37). For example, anaerobic energy release was greater during all-out sprint 427	
exercise for durations of < 120 seconds in hypoxia, such that performance was maintained 428	
relative to normoxia (37). A greater O2 availability in hyperoxia in the present study may 429	
therefore have reduced the potential for anaerobic energy release. This would have impaired 430	
performance at the higher work-rates where the tolerable duration was short, thus accounting 431	
for the decrease in W’. 432	
In conclusion, the present study provides unique insight into the physiological determinants 433	
of the upper limit for steady-state exercise, i.e. CP. The inspiration of hyperoxic gas resulted 434	
in improved microvascular oxygenation (determined by NIRS) when compared to normoxia, 435	
and as a result, CP was increased. Crucially, 𝜏!O2 was unchanged between conditions. These 436	
results underscore the importance of CP as a parameter capable of reflecting aerobic function, 437	
and suggest that, in addition to 𝜏! O2, microvascular O2 availability is an independent 438	
determinant of CP.  439	
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FIGURE LEGENDS 562	
Figure 1. Group mean ± SD critical power (A) and W’ (B) in normoxia and hyperoxia. Open 563	
bars represent group means, whereas dashed black lines represent individual changes in 564	
critical power and W’ between conditions. * indicates significant difference between 565	
conditions. The power-duration relationship of a representative participant in both conditions 566	
is also displayed (C; clear circles: hyperoxia, black circles: normoxia). 567	
Figure 2. A: Group mean pulmonary oxygen uptake (𝑉O2)	responses to moderate exercise in 568	
normoxia (black circles) and hyperoxia (clear circles). Group mean exponential fits are 569	
overlaid onto the 𝑉O2 responses as solid curved lines. Error bars represent SD. B: Pulmonary 570	
oxygen uptake (𝑉O2) responses and best-fit modelled responses of a representative 571	
participant at a single work rate in the normoxic (black circles) and hyperoxic (clear circles) 572	
conditions. Solid curved lines represent modelled fits, horizontal dashed lines represent the 573	
condition-specific 𝑉O2 peak, and vertical dashed lines represent the limit of tolerance. Lines 574	
of residuals are displayed at the bottom for normoxia (black) and hyperoxia (grey).  575	
Figure 3. A: Group mean ± SD [deoxyhaemoglobin + myoglobin] ([HHb + Mb]) responses to 576	
moderate exercise for the rectus femoris (black triangles: normoxia; clear triangles: 577	
hyperoxia) and vastus lateralis (black circles: normoxia; clear circles: hyperoxia) in both 578	
conditions. Group mean exponential fits are overlaid onto the 𝑉O2 responses as solid curved 579	
lines. Error bars represent SD. Vertical dashed black line represents exercise onset. B: Muscle 580	
[deoxyhaemoglobin + myoglobin] ([HHb + Mb]) responses to severe exercise in a 581	
representative participant at a representative work rate for the rectus femoris and vastus 582	
lateralis in both conditions. Residual lines are displayed at the bottom for normoxia (RF: 583	
black dashed line; VL: solid black line) and hyperoxia (RF: grey dashed line; VL: solid grey 584	
line). * indicates significant main effect of condition and # indicates significant main effect of 585	
muscle on both baseline and end-exercise [HHb + Mb] (P < 0.05).  586	
Figure 4. A: Group mean ± SD [oxyhaemoglobin +myoglobin] ([HbO2 + MbO2]) responses 587	
to moderate exercise (black triangles: normoxia; clear triangles: hyperoxia) and vastus 588	
lateralis (black circles: normoxia; clear circles: hyperoxia) in both conditions. Vertical dashed 589	
line represents exercise onset. Error bars respresent SD. B: Muscle [oxyhaemoglobin + 590	
oxymyoglobin] ([HbO2 + MbO2]) responses to severe exercise in a representative participant 591	
at a representative work rate for the rectus femoris and vastus lateralis in both conditions.  * 592	
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